Interpretable multimodal deep learning for real-time pan-tissue pan-disease pathology search on social media.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published Date:

Abstract

Pathologists are responsible for rapidly providing a diagnosis on critical health issues. Challenging cases benefit from additional opinions of pathologist colleagues. In addition to on-site colleagues, there is an active worldwide community of pathologists on social media for complementary opinions. Such access to pathologists worldwide has the capacity to improve diagnostic accuracy and generate broader consensus on next steps in patient care. From Twitter we curate 13,626 images from 6,351 tweets from 25 pathologists from 13 countries. We supplement the Twitter data with 113,161 images from 1,074,484 PubMed articles. We develop machine learning and deep learning models to (i) accurately identify histopathology stains, (ii) discriminate between tissues, and (iii) differentiate disease states. Area Under Receiver Operating Characteristic (AUROC) is 0.805-0.996 for these tasks. We repurpose the disease classifier to search for similar disease states given an image and clinical covariates. We report precision@k = 1 = 0.7618 ± 0.0018 (chance 0.397 ± 0.004, mean ±stdev ). The classifiers find that texture and tissue are important clinico-visual features of disease. Deep features trained only on natural images (e.g., cats and dogs) substantially improved search performance, while pathology-specific deep features and cell nuclei features further improved search to a lesser extent. We implement a social media bot (@pathobot on Twitter) to use the trained classifiers to aid pathologists in obtaining real-time feedback on challenging cases. If a social media post containing pathology text and images mentions the bot, the bot generates quantitative predictions of disease state (normal/artifact/infection/injury/nontumor, preneoplastic/benign/low-grade-malignant-potential, or malignant) and lists similar cases across social media and PubMed. Our project has become a globally distributed expert system that facilitates pathological diagnosis and brings expertise to underserved regions or hospitals with less expertise in a particular disease. This is the first pan-tissue pan-disease (i.e., from infection to malignancy) method for prediction and search on social media, and the first pathology study prospectively tested in public on social media. We will share data through http://pathobotology.org . We expect our project to cultivate a more connected world of physicians and improve patient care worldwide.

Authors

  • Andrew J Schaumberg
    Memorial Sloan Kettering Cancer Center and the Tri-Institutional Training Program in Computational Biology and Medicine, New York, NY, USA. ajs625@cornell.edu.
  • Wendy C Juarez-Nicanor
    Weill Cornell High School Science Immersion Program, New York, NY, USA.
  • Sarah J Choudhury
    Weill Cornell High School Science Immersion Program, New York, NY, USA.
  • Laura G Pastrián
    Department of Pathology, Hospital Universitario La Paz, Madrid, Spain.
  • Bobbi S Pritt
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Minneapolis, MN, USA.
  • Mario Prieto Pozuelo
    Laboratorio de Dianas Terapéuticas, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • Ricardo Sotillo Sánchez
    Departamento de Patología, Virgen de Altagracia Hospital, Manzanares, Spain.
  • Khanh Ho
    Département de Pathologie, Centre Hospitalier de Mouscron, Manzanares, Belgium.
  • Nusrat Zahra
    Department of Pathology, Allama Iqbal Medical College, Lahore, Pakistan.
  • Betul Duygu Sener
    Department of Pathology, Konya Training and Research Hospital, Konya, Turkey.
  • Stephen Yip
  • Bin Xu
    Department of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Srinivas Rao Annavarapu
    Department of Cellular Pathology, Royal Victoria Infirmary, England, UK.
  • Aurélien Morini
    Faculté de médecine de Créteil, Université Paris Est Créteil, Créteil, France.
  • Karra A Jones
    Department of Pathology, University of Iowa, Iowa City, IA, USA.
  • Kathia Rosado-Orozco
    HRP Labs, San Juan, PR, USA.
  • Sanjay Mukhopadhyay
    Department of Pathology, Cleveland Clinic, Cleveland, OH, USA.
  • Carlos Miguel
    Department of Pathology, Centro Médico de Asturias, Oviedo, Spain.
  • Hongyu Yang
    Department of Pathology, St Vincent Evansville Hospital, Evansville, IN, USA.
  • Yale Rosen
    Department of Pathology, SUNY Downstate Medical Center, New York, NY, USA.
  • Rola H Ali
    Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
  • Olaleke O Folaranmi
    Department of Pathology, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
  • Jerad M Gardner
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AK, USA.
  • Corina Rusu
    Department of Pathology, Augusta Hospital, Bochum, Germany.
  • Celina Stayerman
    Laboratorio TechniPath, San Pedro Sula, Honduras.
  • John Gross
    Bone and Soft Tissue and Surgical Pathology, Mayo Clinic, Rochester, MN, USA.
  • Dauda E Suleiman
    Department of Histopathology, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
  • S Joseph Sirintrapun
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mariam Aly
    Department of Psychology, Columbia University, New York, NY, USA. ma3631@columbia.edu.
  • Thomas J Fuchs
    Weill Cornell Medicine, New York, USA; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: gac2010@med.cornell.edu.